Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

SAGE KE Bulletin Board

Eukarion antioxidant efficacy in Flies

5 December 2002

Florian Muller

Dear Simon,

Thanks for taking the time to clarify this issue! I am wondering: Wouldn't it be simplest to settle this issue of oral bioavailability by checking whether the EUK compunds can rescue an sod1 deficient mutant in Drosophila (or I guess now there is a sod2 knockdown)?

Since the oral bioavailability is low in mammals, does this mean you have to inject them for the entirety of the lifespan (when doing aging studies)?

I am pretty sure you always do your rescues in the B6D2 F2 right? Did you get a smaller/larger rescue with the EUK's when doing this in the C57 or DBA?



To Advertise     Find Products

Science of Aging Knowledge Environment. ISSN 1539-6150